ArticleCancers2026

Real-World Outcomes of Primary Versus Interval Debulking Surgery in a Multicenter Cohort of Advanced Ovarian Cancer Patients Treated with Bevacizumab.

Kaja Michalczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.